Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs
Vincenzo Belcastro(Aziende Socio Sanitarie Territoriale Lodi), Francesco Pisani(Azienda Ospedaliero Universitaria San Giovanni Battista), Cinzia Costa(Diagnostics for the Real World (United States)), Riccardo Ientile(University of Messina), Daniela Caccamo(University of Messina), G. Oteri(University of Messina), Maria Grazia Marciani(University of Rome Tor Vergata), Umberto Aguglia(Martin University), Pasquale Striano(Great Ormond Street Hospital), Paolo Calabresi(Università Cattolica del Sacro Cuore), Gaetano Gorgone, Laura Rosa Pisani(Regenxbio (United States)), Salvatore Striano(Federico II University Hospital), C. Ciampa(Federico II University Hospital)
Cited by 101
Related Papers
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
|New England Journal of Medicine|2008|811
Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction
|Cell Death and Disease|2023|710
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences
|Current Neuropharmacology|2018|368